Log in to save to my catalogue

The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in t...

The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7609841

The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in the mouse

About this item

Full title

The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in the mouse

Publisher

United States: Society for the Study of Reproduction

Journal title

Biology of reproduction, 2020-11, Vol.103 (5), p.1132-1143

Language

English

Formats

Publication information

Publisher

United States: Society for the Study of Reproduction

More information

Scope and Contents

Contents

Sirolimus, also known as rapamycin, and its closely related rapamycin analog (rapalog) Everolimus inhibit “mammalian target of rapamycin complex 1” (mTORC1), whose activity is required for spermatogenesis. Everolimus is Food and Drug Administration approved for treating human patients to slow growth of aggressive cancers and preventing organ transp...

Alternative Titles

Full title

The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in the mouse

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7609841

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7609841

Other Identifiers

ISSN

0006-3363

E-ISSN

1529-7268

DOI

10.1093/biolre/ioaa130

How to access this item